Skip to content
Rare Medication

Shortage status

Moxidectin shortage - supply and sourcing support

No.

Moxidectin is not on the FDA drug shortage list.

FDA status
Not listed
List covers
United States market
Checked
20 Sept 2026

Source: FDA drug shortage database - checked 20 Sept 2026 - open the FDA record

The FDA list covers national supply in the United States, so a medicine can still be hard to get where you are: one strength, brand or pack size may be out at your pharmacy while there is no national shortage.

A shortage rarely means a medicine has vanished. Usually one presentation is short while others keep shipping, and how long it lasts depends on why it started. Below is what is known about Moxidectin supply right now, what tends to be affected, and what you can do about it today. Shortages usually start with one of four things: a manufacturing problem at a plant, a shortage of the raw ingredient, a jump in demand, or a maker leaving the market. The first two tend to resolve in months, the last one does not.

What to do now

  1. 1National supply is not restricted, so this is a local stock question. Call ahead before travelling to a pharmacy.
  2. 2Ask whether they can order it in. Most pharmacies can get a stocked medicine within a day or two.
  3. 3Still nowhere to be found near you? Tell us the exact presentation and we will check licensed suppliers.
Ask us to find it

What usually goes short, and what does not

Shortages hit a presentation, not an ingredient: one strength, one pack size, or one manufacturer's line. A different strength of the same medicine, or the same strength from another maker, is often still available, which is why the first question to a pharmacy is not «do you have it» but «which of these do you have».

Teams revisit Moxidectin when wholesaler tiers signal constraints, when clinical programs require a specific presentation, or when regional registration limits usual channels.

A submitted inquiry does not create a contractual obligation to supply and does not replace approvals required by your institution or regulators.

Market signals and documentation

Confirm the International Nonproprietary Name (INN) for your request: Moxidectin. Trade names and pack sizes vary by market.

Therapeutic context often referenced in procurement for this entry: Hospital medicines. This does not replace clinical protocols.

For quotation review, teams typically prepare: strength, dosage form, pack size, destination country, and organization billing or licensing identifiers as required by your process.

Availability may depend on jurisdiction and regulatory status. Your compliance team should validate import and dispensing requirements.

Trust: compliant shortage support

Shortage pressure should not push buyers toward informal channels. If a request cannot proceed, you should receive a clear outcome rather than ambiguous promises.

  • Reviews are handled with procurement and compliance framing in mind, including destination country and product authorization context.
  • Procurement questions related to Moxidectin are reviewed in line with authorized wholesale norms and destination-country rules.
  • We do not facilitate unlicensed sales, personal import for resale, or circumvention of prescribing rules.
  • If follow-up is possible, it should stay within authorized wholesale and documentation norms for your jurisdiction.

Request availability for your organization

Next step: Start a structured availability assessment with our B2B workflow. Include organization context so reviewers can assess feasibility responsibly. No payment or purchase obligation at submission.

Why teams use structured shortage inquiries

When usual channels are constrained, a clear procurement request helps reviewers assess feasibility without bypassing law or institutional controls.

  • Licensed healthcare organizations and professional procurement contacts only
  • Quotation-based review - no obligation and no guaranteed allocation
  • Documentation expectations explained during follow-up where applicable
  • Aligned with distributor advisories and your local compliance rules

Frequently asked questions